Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)
Recruiting in Palo Alto (17 mi)
+20 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: AcuFocus, Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the long-term safety of the IC-8 Apthera intraocular lens (IOL).
Eligibility Criteria
Inclusion Criteria
Enrolled in Investigational Device Exemption (IDE) G180075 study and implanted with the IC-8 Apthera intraocular lens (IOL)
Able to comprehend and have signed a statement of informed consent
Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visit(s)
Treatment Details
Interventions
- IC-8 Apthera Intraocular Lens (IOL) (Procedure)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Pepose Vision InstituteSaint Louis, MO
Virginia Eye ConsultantsNorfolk, VA
Advanced Vision CareLos Angeles, CA
Cleveland Eye ClinicBrecksville, OH
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
AcuFocus, Inc.Lead Sponsor